Amplification of the PAK4 gene and dysregulated activation of the PAK4 protein are commonly observed in ovarian cancer, breast carcinoma, and pancreatic carcinoma (Ha et al., 2015; Won et al., 2019). Here, PAK4 is linked to breast carcinoma.